What disease does Gefitinib treat?

Gefitinib (Gefitinib) is a drug used to treat non-small cell lung cancer (Non-Small Cell Lung Cancer, NSCLC). It is an oral targeted therapy for patients with NSCLC who have specific epidermal growth factor receptor (EGFR) mutations.

EGFRmutations are a common genetic mutation in some NSCLC patients that cause lung cancer cells to overgrow and spread. Gefitinib, as a tyrosine kinase inhibitor (TKI), inhibits the growth and division of lung cancer cells by interfering with the activity of the EGFR signaling pathway, thereby preventing further tumor development.

In clinical practice, gefitinib is often used to treat patients with advanced or metastatic NSCLC with EGFR mutations, especially those who are ineffective or intolerant to traditional chemoradiotherapy. The targeting properties of this drug enable it to attack cancer cells in a more targeted manner. Compared with traditional chemotherapy methods, it can reduce many adverse reactions and improve patients' quality of life.

However, it is worth noting that gefitinib is not suitable for allNSCLC patients. It is mainly used for those EGFR mutation-positive patients. Treatment regimen and dosage will be adjusted based on the patient's specific condition and the recommendations of the physician. When using gefitinib, patients need to be under the supervision of a doctor to ensure the effectiveness and safety of the treatment.

Gefitinib was launched in China in 2005. At that time, the price of a box was about 5,000 yuan. 2017After entering medical insurance in China, the price after medical insurance has dropped a lot. For specific prices after medical insurance, please consult the local hospital pharmacy or medical insurance bureau. Other versions include original drugs and cost-effective generic drugs. Generic drugs include generic drugs from India, Bangladesh and Laos. The prices vary with different specifications, about 200~800yuan, and the ingredients of generic drugs are basically the same as domestic drugs.